Back to Explorer
AI-driven drug discovery
US
Founded 2013
700 employees
$890.0M raised
Funding & Financials
Total Funding
$890.0M
Last Round
IPO
Valuation
$3.0B
Revenue Estimate
$51.0M
Company Type
public
Ticker
RXRX
Last Round Date
2021-04
Investors
Public company
Notes
Computational biology
Strategic Scores
Thesis Fit8/10
Alignment with key investment themes
Overcrowded7/10
Category density relative to landscape
Strategic Importance6/10
Layer importance, uniqueness, maturity
Stack Position
Layer
Application
Category
Vertical AI
Subcategory
Drug Discovery